Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.180
+0.040 (1.87%)
At close: May 22, 2025, 4:00 PM
2.110
-0.070 (-3.21%)
After-hours: May 22, 2025, 6:05 PM EDT
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $204.63 million as of May 22, 2025. Its market cap has increased by 0.64% in one year.
Market Cap
204.63M
Enterprise Value
148.47M
1-Year Change
0.64%
Ranking
Category
Stock Price
$2.18
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $204.63M, an increase of 63.42%. That is a compound annual growth rate of 4.15%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.81B |
| Johnson & Johnson | 368.56B |
| AbbVie | 321.13B |
| Novo Nordisk | 308.07B |
| UnitedHealth Group | 274.85B |
| Abbott Laboratories | 231.49B |
| Novartis AG | 222.59B |
| AstraZeneca | 218.71B |